Drug Adenosine A2a Receptors

Nourianz

Payments companies reported to CMS as associated with Nourianz. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.9Massociated payments (2023-2025)
3,510clinicians with associated payments
3companies reporting

By year

2023 $1.2M
2024 $720K
2025 $14K

Payments reported as associated with Nourianz, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $1.8M
Family $28K
Psychiatry $21K
Physician Assistant $16K
Nurse Practitioner $16K
Neurological Surgery $8,626

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Nourianz

These are the largest totals companies reported as associated with Nourianz. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Jill Giordano Farmer Philadelphia, PA Neurology (Psychiatry & Neurology) $131,910.91
Cherian Karunapuzha Oklahoma City, OK Neurology (Psychiatry & Neurology) $117,639.40
Stuart Isaacson Boca Raton, FL Neurology (Psychiatry & Neurology) $101,418.78
Ramsey Falconer Alexandria, VA Neurology (Psychiatry & Neurology) $95,258.86
Michael Soileau Georgetown, TX Neurology (Psychiatry & Neurology) $89,011.26
Lori Guyton Herrin, IL Neurology (Psychiatry & Neurology) $78,568.43
Alexander Shtilbans New York, NY Neurology (Psychiatry & Neurology) $64,627.45
Nirav Pavasia Dallas, TX Neurology (Psychiatry & Neurology) $62,371.55
Khashayar Dashtipour Loma Linda, CA Neurology (Psychiatry & Neurology) $61,031.00
Laxman Bahroo Washington, DC Neurology (Psychiatry & Neurology) $59,544.92

Prescribed Nourianz?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.